Ramot at Tel Aviv University has signed a collaboration agreement with Bayer to develop and validate a platform for in vitro cardiotoxicity screening, using human heart tissues 3D-printed in Prof. Tal Dvir‘s Laboratory for Tissue Engineering and Regenerative Medicine at Tel Aviv University (TAU). Prof. Dvir’s team and Bayer plan to test new medications for… Read More
An international research team led by Dr. Tali Ilovitsh of the Biomedical Engineering Department at TAU developed a noninvasive technology platform for gene delivery into breast cancer cells. The technique combines ultrasound with tumor-targeted microbubbles. Once the ultrasound is activated, the microbubbles explode like smart and targeted warheads, creating holes in cancer cells’ membranes, enabling… Read More
During sleep and under anesthesia, we rarely respond to such external stimuli as sounds even though our brains remain highly active. Now, a series of new studies by researchers at Tel Aviv University‘s Sackler Faculty of Medicine and Sagol School of Neuroscience find, among other important discoveries, that noradrenaline, a neurotransmitter secreted in response to… Read More
Researchers at Tel Aviv University have discovered evidence of ear infections in the skull remains of humans living in the Levant some 15,000 years ago. “Our research seeks to determine the impact of our environment on illnesses in different periods,” says lead author Dr. Hila May of the Department of Anatomy and Anthropology at TAU’s… Read More
A team of Tel Aviv University researchers led by Dr. Adi Stern of the School of Molecular Cell Biology and Biotechnology at TAU’s George S. Wise Faculty of Life Sciences have conducted the first large-scale genomic sequencing of the novel coronavirus strain that has infected to date over 16,500 people in Israel. The scientists harnessed… Read More
Tel Aviv University researchers have developed a new test to add to the current diagnostic arsenal used to detect coronavirus infection. The test is serological — based on blood samples — and measures the presence of antibodies against the virus. It can be used to assess the full extent of the spread of the virus… Read More
The race to develop effective antibody-based treatments for COVID-19 is advancing at a rapid pace. Now, a Tel Aviv University laboratory reports it has successfully isolated two antibodies that would neutralize the virus’s ability to infect human cells. The two suitable antibodies were identified in patients recovering from COVID-19, according to Dr. Natalia Freund, who… Read More
Together with COVID-19 Sprint, a technology task force led by Assuta Ashdod Hospital, Rafael Advanced Technology and Weizmann Institute of Science, a doctoral student at Tel Aviv University‘s Iby and Aladar Fleischman Faculty of Engineering is helping to develop an inexpensive disposable ventilator specifically tailored to treat COVID-19 patients. It’s called MANSHEMA, is cheap, suitable… Read More